Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (vol 123, pg 26, 2020)

被引：0
|
作者：
Gelsomino, Francesco [1 ]
Tiseo, Marcello [1 ]
Barbieri, Fausto [1 ]
Riccardi, Ferdinando [1 ]
Cavanna, Luigi [1 ]
Frassoldati, Antonio [1 ]
Delmonte, Angelo [1 ]
Longo, Lucia [1 ]
Dazzi, Claudio [1 ]
Cinieri, Saverio [1 ]
Colantonio, Ida [1 ]
Sperandi, Francesca [1 ]
Lamberti, Giuseppe [1 ]
Brocchi, Stefano [1 ]
Tofani, Lorenzo [1 ]
Boni, Luca [1 ]
Ardizzoni, Andrea [1 ]
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy
来源：
BRITISH JOURNAL OF CANCER | 2021年 / 125卷 / 02期
关键词：
D O I：
10.1038/s41416-021-01439-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [41] A phase II trial of nab-paclitaxel and gemcitabine in patients with non-small cell lung cancer previously treated with platinum based chemotherapy
    Hatakeyama, Y.
    Tachihara, M.
    Kiriu, T.
    Hata, A.
    Nagano, T.
    Yamamoto, M.
    Kobayashi, K.
    Ohnishi, H.
    Katakami, N.
    Nishimura, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S102 - S102
  • [42] Trial in progress: A multicenter phase Ib/II study of pelcitoclax (APG-1252) in combination with paclitaxel in patients with relapsed/refractory small-cell lung cancer (R/R SCLC).
    Qin, Angel
    Kalemkerian, Gregory Peter
    Patel, Jyoti D.
    Mohindra, Nisha Anjali
    Carlisle, Jennifer W.
    Sands, Jacob
    He, Zhicong
    Winkler, Robert
    Liang, Zhiyan
    Hammock, Vakessa
    Bombelli, Riccardo
    Lu, Ming
    Xu, Yang
    Fu, Tommy
    Wang, Cunlin
    Yang, Dajun
    Zhai, Yifan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
    Gridelli, Cesare
    Chen, Tianlei
    Ko, Amy
    O'Brien, Mary E.
    Ong, Teng Jin
    Socinski, Mark A.
    Postmus, Pieter E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1445 - 1451
  • [44] Doxorubicin and Topotecan for Relapsed/Refractory Small Cell Lung Cancer (SCLC): A FPBCC Clinical Trials Network Phase I Study
    Umakanthan, J. Manikkam
    Marr, A.
    Ernani, V.
    Kessinger, M.
    Smith, L.
    Tijerina, J.
    Radniecki, S.
    Kosmacek, E.
    Ketcham, M.
    Ganti, A. K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2188 - S2188
  • [45] Phase II study of weekly cisplatin, etoposide and irinotecan (PE/CPT) for refractory relapsed small cell lung cancer (SCLC).
    Kim, Y.
    Goto, K.
    Nishiwaki, Y.
    Kubota, K.
    Omatsu, H.
    Tamura, T.
    Ohe, Y.
    Kunitoh, H.
    Sekine, I.
    Yamamoto, N.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 386S - 386S
  • [46] Pemetrexed (P) in relapsed small cell lung cancer (SCLC): Preliminary results of a phase II trial
    Raju, R. N.
    Neubauer, M. A.
    Smith, D. A.
    Richards, D. A.
    Asmar, L.
    Cunneen, J. L.
    Chen, R.
    Tai, D. F.
    Obasaju, C. K.
    Socinski, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC)
    Vigano, M. G.
    Cavina, R.
    Novello, S.
    Grossi, F.
    Santoro, A.
    Gregorc, V.
    Scagliotti, G.
    Garassino, I. M.
    Rossoni, G.
    Levra, M. G.
    Genova, C.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Phase II Trial of NGR-hTNF and Doxorubicin in Relapsed Small Cell Lung Cancer (SCLC)
    Vigano, M.
    Cavina, R.
    Novello, S.
    Grassi, F.
    Santoro, A.
    Gregorc, V.
    Rossoni, G.
    Levra, M. G.
    Lambiases, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S623 - S623
  • [49] Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study
    Kakolyris, S
    Mavroudis, D
    Tsavaris, N
    Souglakos, J
    Tsiafaki, P
    Kalbakis, K
    Agelaki, S
    Androulakis, N
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 193 - 197
  • [50] Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer (vol 29, pg 139, 2018)
    Overman, M. J.
    Adam, L.
    Raghav, K.
    Wang, J.
    Kee, B.
    Fogelman, D.
    Eng, C.
    Vilar, E.
    Shroff, R.
    Dasari, A.
    Wolff, R.
    Morris, J.
    Karunasena, E.
    Pisanic, T. R., II
    Azad, N.
    Kopetz, S.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 495 - 495
12345